Pharmaceutical Industry

Manufacturing Pharmaceuticals Drug Development Drug Development Corporate Strategy Trade Policy Research and Development Drug Manufacturing AstraZeneca Stock Market

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

AstraZeneca’s partnership with CSPC taps AI to advance chronic disease candidates against a backdrop of ongoing Chinese regulatory scrutiny.

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

Charles River Labs Reshapes Board and Launches Strategic Review Following Elliott Deal

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

India Bans 35 Unapproved Fixed-Dose Combination Drugs

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

Senators Question RFK Jr.'s Mar-a-Lago Dinners with Big Pharma Executives

Alliance Pharma Backs £362m Takeover by DBAY Advisors

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe